Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Study of Tazemetostat in Combination With Lenalidomide & Rituximab in R/R FL

64 views
June 8, 2022
0 Comments
Login to view comments. Click here to Login